Altesa BioSciences, a clinical-stage pharmaceutical company dedicated to improving the lives of people with chronic lung diseases including COPD and asthma, today announced the enrollment of the first ...

Nebuliser use in COPD is most common in severe disease with frequent exacerbations, high symptoms, and reduced lung function.

Pneumonia is responsible for a tremendous burden of disease worldwide. In the U.S., it is a leading cause of death due to ...

Dupilumab reduced airway inflammation and mucus burden and enhanced airway volume and flow, which led to better lung function and improved asthma control in patients with moderate to severe type 2 ...

A pair of studies presented at the European Respiratory Society Congress 2024 emphasized the importance of close monitoring and proactive treatment approaches for patients with idiopathic (IPF) and ...

"Small lung syndrome" is proposed to address persistent low lung volume linked with comorbidities, requiring a new ICD code for accurate diagnosis. Early intervention in lung function trajectories can ...

A clinical trial conducted in a neonatal intensive care unit has identified a new treatment protocol to improve lung growth and function among preterm infants. Adding two weeks of continuous positive ...

Please provide your email address to receive an email when new articles are posted on . Between a group of carpenters and an age-, sex- and height-matched group of university employees, carpenters had ...

Healthcare professionals may consider lung nodule surgery when they suspect a person’s nodules are cancerous, if they are growing quickly, or causing additional symptoms. Various factors, including ...